



- Công bố khoa học và công nghệ Việt Nam
76
Ung thư học và phát sinh ung thư
Mai Văn Viện, Lê Hải Sơn, Nguyễn Thị Minh Phương, Nguyễn Thị Nga, Phan Quốc Hoàn(1), Lý Tuấn Khải, Bùi Tiên Sỹ, Nguyễn Thị Thủy, Nguyễn Thị Duyên
Ghép tế bào gốc tạo máu tự thân điều trị bệnh nhân nhược cơ có u tuyến ức kháng trị
Autologous hematopoietic stem cell transplantation for refractory myasthenia gravis with thymoma
Tạp chí Y học Việt Nam (Tổng hội Y học Việt Nam)
2022
CD1
382-390
1859-1868
TTKHCNQG, CVv 46
- [1] Rebeiro P., Moore J. (2016), The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders,Intern Med J
- [2] Burman J., Iacobaeus E., Svenningsson A., et al. (2014), Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience,J Neurol Neurosurg Psychiatry
- [3] Pasquini M.C., Voltarelli J., Atkins H.L., et al. (2012), Transplantation for autoimmune diseases in North and South America: a report of the Center for International Blood and Marrow Transplant Research,Biol Blood Marrow Transplant
- [4] Farge D., Labopin M., Tyndall A., et al. (2010), Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases,Haematologica
- [5] Bryant A., Atkins H., Pringle C.E., et al. (2016), Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation,JAMA Neurol
- [6] Sussman J., Farrugia M.E., Maddison P., et al. (2015), Myasthenia gravis: Association of British Neurologists’ management guidelines,Practical Neurology
- [7] Gomez A.M., Vrolix K., Martinez-Martinez P., et al. (2011), Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis,J Immunol
- [8] Sanders D.B., Wolfe G.I., Benatar M., et al. (2016), International consensus guidance for management of myasthenia gravis: Executive summary,Neurology
- [9] Dresser L., Wlodarski R., Rezania K., Soliven B. (2021), Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations,J Clin Med
- [10] Koneczny I., Herbst R. (2019), Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture,Cells
- [11] Ng S.-A., Sullivan K.M. (2019), Application of stem cell transplantation in autoimmune diseases,Curr Opin Hematol
- [12] Díaz-Manera J., Rojas García R., Illa I. (2012), Treatment strategies for myasthenia gravis: an update,Expert Opin Pharmacother
- [13] Kaminski H.J., Kusner L.L. (eds.) (2018), Myasthenia Gravis and Related Disorders,